Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02780674”
into the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D6080C00001” into the search box and click “Find a Study”.
Full Trial Title: A Phase 1, Randomized, Blinded, Single-Dose, Dose Escalation
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of
MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
AstraZeneca Protocol Number: D6080C00001
MedImmune, LLC, a member of the AstraZeneca Group of companies, sponsored
this study and has its headquarters at 1800 Concord Pike, Wilmington, DE 19850.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and
find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510
Boston, MA 02109
1-877-MED-HERO
www.ciscrp.org
Version: V2.0 10/2018 4